Central Pacific Bank Trust Division Biomarin Pharmaceutical Inc Transaction History
Central Pacific Bank Trust Division
- $793 Billion
- Q3 2024
A detailed history of Central Pacific Bank Trust Division transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 4,550 shares of BMRN stock, worth $304,941. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,550
Previous 4,550
-0.0%
Holding current value
$304,941
Previous $375 Million
14.62%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.52 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.29 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.26 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$931 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$703 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...